Related Experiment Video
Updated: Dec 30, 2025

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
Invoking death: How oncologists discuss a deadly outcome
1Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, MC1005, M200, Chicago, IL 60637, United States.
Physicians discuss patient death not only at end-of-life but also during treatment discussions. They invoke the possibility of death to persuade patients toward recommended treatments, leveraging authority for specific outcomes.
Area of Science:
- Medical Sociology
- Conversation Analysis
- Clinical Communication
Background:
- Sociological research indicates patient and physician reluctance to discuss death during end-of-life care.
- Existing analyses often limit the scope of death discussions to terminal prognoses.
Purpose of the Study:
- To investigate how physicians discuss death in oncology consultations beyond the end-of-life context.
- To analyze the function and frequency of death invocations in medical interactions.
Main Methods:
- Utilized conversation analysis (CA) to examine a corpus of 90 video-recorded oncology visits.
- Expanded analytical parameters to include mentions of death outside of strictly end-of-life scenarios.
Main Results:
- Physicians frequently invoke the possibility of patient death during treatment recommendation discussions.
- Death invocations serve as a persuasive tactic to overcome patient resistance to recommended treatments.
- Mentions of death were also observed when resistance was anticipated but not explicitly expressed.
Conclusions:
- Physicians utilize discussions of death as a strategy to advocate for specific treatment plans.
- Invoking death leverages physician authority to influence treatment decisions and achieve desired outcomes.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

